Since Src could phosphorylate TOPK at Y74 in vitro (Figure 1) and ex vivo (Figure 2), what we explored next was if the phosphorylation of TOPK at Y74 was inhibited in colon cancer cells expressing low levels of Src. Here, PBK is linked to malignant colon neoplasm.